Sight Sciences Valuation
| SGHT Stock | USD 2.46 0.07 2.77% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Sight Sciences has a current Real Value of $2.95 per share. The regular price of the company is $2.46. Our model measures the value of Sight Sciences from inspecting the company fundamentals such as Operating Margin of (0.56) %, return on equity of -0.45, and Shares Outstanding of 50.4 M as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Sight Sciences' price fluctuation is unstable at this time. Calculation of the real value of Sight Sciences is based on 3 months time horizon. Increasing Sight Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Sight Sciences' intrinsic value may or may not be the same as its current market price of 2.46, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.46 | Real 2.95 | Hype 2.31 | Naive 2.35 |
The intrinsic value of Sight Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sight Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sight Sciences helps investors to forecast how Sight stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sight Sciences more accurately as focusing exclusively on Sight Sciences' fundamentals will not take into account other important factors: Sight Sciences Total Value Analysis
Sight Sciences is at this time forecasted to have valuation of 40.7 M with market capitalization of 123.98 M, debt of 35.41 M, and cash on hands of 220.1 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Sight Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
40.7 M | 123.98 M | 35.41 M | 220.1 M |
Sight Sciences Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.34. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sight Sciences recorded a loss per share of 1.01. The entity had not issued any dividends in recent years. Based on the key indicators related to Sight Sciences' liquidity, profitability, solvency, and operating efficiency, Sight Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Sight Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sight Sciences has an asset utilization ratio of 48.64 percent. This implies that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that Sight Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Sight Sciences Ownership Allocation
Sight Sciences shows a total of 50.4 Million outstanding shares. Over half of Sight Sciences' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sight Sciences Profitability Analysis
The company reported the previous year's revenue of 81.06 M. Net Loss for the year was (55.55 M) with profit before overhead, payroll, taxes, and interest of 67.7 M.About Sight Sciences Valuation
The stock valuation mechanism determines Sight Sciences' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Sight Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sight Sciences. We calculate exposure to Sight Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sight Sciences's related companies.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company was incorporated in 2010 and is headquartered in Menlo Park, California. Sight Sciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 212 people.
Sight Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Sight Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 48.6 M |
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.